Friday, 25 May 2018

You are here

The RheumNow Week in Review – 6 May 2016

Highlights from this week on include:

  1. Registry study (ARTIS & DANBIO) of Spondyloarthritis & Psoriatic arthritis patients show NO cancer risk associated with SpA or PsA; moreover TNF inhibitor use does not augment the cancer risk in these patients. 
  2. May is lupus awareness month. 
  3. CARDERA-2 clinical trial of 154 early RA pts showed that Anakinra+MTX was not better than MTX alone- in early RA - both Xray & clinical outcomes. Questions the value of anakinra in RA.  
  4. Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis 
  5. Acute scrotal swelling in Henoch Schonlein purpura occurs in 10-30% of boys, 60% are unilateral.  Treatment with steroids? 
  6. Late onset SLE (>50yrs) patients have less cutaneous disease (malar rash, photosensitivity, livedo) but more Sicca Sx 
  7. Metanalysis: TNF inhibitors are shown to be associated with an increase risk of perioperative infections (SSI): BUT the infection risk decreases >38% with temporary cessation of TNFi before surgery. 
  8. Dr. Nicola Dalbeths #Gout review in Lancet is stellar! She's leading the field w/ DECT scans, research & smart Rx. 
  9. RheumNow posts a free download – Patient Guide to Biologics  
  10. FDA REMS/Safety Panel Backs Educational Requirements for Opioid Prescribers 
  11. Simple Referral Rule May Lead to Earlier Referral and Diagnosis of Axial Spondyloarthritis. Rule: needs to 2 of 4 to refer suspected SpA – 1) inflammatory low back pain; 2) back pain > 5 yrs.; 3) good response to NSAIDs; and 4) family history of spondyloarthritis. 
  12. CDC Updates Arthritis Numbers – 25% of US adults have arthritis. 
  13. Poor Outcomes for Dermato/Polymyositis Admitted to ICU. 
  14. Can Rituximab Change the Course of Interstitial Lung Disease.  
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past weeks news from - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.